-
Archives
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- September 2008
- August 2008
- July 2008
-
Meta
Tag Archives: Pfizer
Crizotinib Targets Gene To Stop Lung Cancer Tumors in 90% of Treated Patients
The drug Crizotinib (PF0234-1066) was shown to shrink or stabilize tumors in about 90% of the patients who took it. [...]
Posted in Genetics
Tagged ASCO, Crizotinib, EML4-ALK, lung cancer, PF-0234-1066, Pfizer, Seoul National University, Yue-Jue Bang
24 Comments
Athersys Secures Stem Cell Patents and Stock Swells
Biopharmaceutical company Athersys (NASDAQ: ATHX) received a major boost in its stock price on February 10th, following the announcement that [...]
Posted in Stem Cells
Tagged Angiotech, Athersys, MultiStem, patent, Pfizer, Stem Cells, stocks
5 Comments
Two New Studies Cast Doubt on Resveratrol
New work produced by Pfizer and Amgen cast doubt on the manner in which health supplement resveratrol is said to [...]
Posted in Longevity And Health
Tagged Amgen, GSK, health supplements, Pfizer, resveratrol, SIRT1, SRT1720
29 Comments